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Abstract 
An estimated 46 million adults in the U.S. are affected by arthritis, 
with osteoarthritis (QA) being the most common. Due to the limlted 
pharmacologic therapy available to treat this condition, many pa-
tients are turning to dietary supplements to relieve their symptoms. 
Some of the most popular supplements available for the treatment 
of QA are glucosamine, choneroitin and methylsulfonylmethane 
'MSM}, but mamy less studied products are also available. Due to 
limited eviderace of efficacy, It is difficult to make a strong recom-
mendation for any of these pr©ductSi however, pharmacists must be 
able to educate the patients that choose to use these supplements 
in the treatment of their OA. 
Introduction 
Arthritis currently affects an estimated 46 million adults in the United 
States alone, and rates are expected to rise dramatically to 67 mil-
lion over the next 20 years. It is most common in adults 65 years and 
older and consists of more than 100 different rheumatic diseases and 
conditions that impact joints, joint tissue and other connective tissue. Os-
teoarthritis (OA) is the most common and is defined as the degeneration 
of a joint's cartilage and underlying bone, leading to pain, inflammation 
and stiffness in the joint. Due to the high prevalence, high lifetime risk of 
developing OA and many other factors, this disease has become an im-
portant public health concern. It is currently the nation's leading cause of 
disability, causing limited activity in approximately 19 million U.S. adults. 
Due to the fact that it is so difficult for people to be physically active with 
OA, it is a high risk factor for many other chronic diseases and condi-
tions, including obesity, diabetes and cardiovascular disease. Arthritis 
has been a large expense for the Uni~ed States over the past several 
years, costing a total of $128 billion in 2003 alone. It is the reason for 
approximately 992, 100 hospital visits and 44 million outpatient visits 
every year.1 
In order to address this rising concern with arthritis, there are many 
counseling points that pharmacists may give to their patients affected 
by this disease. Advising patients to be physically active, maint~i~ a 
healthy body weight, protect their joints, and schedule regular v1s1ts . 
with a physician or even referring them to a self-management education 
program can be extremely beneficial.1 The mainstay over-the-counter 
treatment option for relieving symptoms of OA is acetaminophen. Pre-
scription treatment options are few, including COX-2 inhibitors, NSAIDs 
and even prednisone; however, these drugs do not come without their 
own adverse effects and risks. Often, patients with OA look to other 
means of easing the pain and inflammation. Supplements are becoming 
increasingly popular treatment options for those affected by the disease; 
however, patients need to be cautious when purchasing these products. 
Some of the most popular supplements available for the treatment of OA 
include glucosamine, chondroitin and methylsulfonylmethane (MSM). 
Glucosamine 
Glucosamine is arguably the most popular supplement used for joint 
health. There have been more than 20 studies performed to assess the 
efficacy of glucosamine alone and in combination with other supple-
ments to treat osteoarthritis of the knee.2-6The outcomes of these trials 
have been mixed; for every study performed that finds glucosamine ef-
fective, another study has been performed to find it ineffective. It is also 
interesting to note that many trials backed by pharmaceutical companies 
yielded clinically significant outcomes, whereas many independently 
funded trials found no clinically significant outcomes. Despite many 
mixed outcomes, there have been two large trials that suggest glucos-
amine could benefit some patient populations. The European GUIDE 
trial compared the efficacy of glucosamine sulfate alone (1,500 mg once 
daily) and acetaminophen (3,000 mg once daily) in treating osteoarthri-
tis.7 The 318 enrolled patients were followed for six months, and results 
proved glucosamine to be more effective than acetaminophen in treating 
pain. The most recent American GAIT trial followed 1,500 patients for 
six months and then 750 of those patients for an additional 18 months. 
Patients were randomized to glucosamine HCL alone, chondroitin sul-
fate alone, glucosamine/chondroitin combination, celecoxib, or placebo.8 
The glucosamine/chondroitin combination was the only group besides 
celecoxib to show significant reductions in pain, but this was only noted 
in the group of patients who had the most severe pain index at study 
onset. Interestingly, there was also a 55 percent placebo effect in this 
group of patients. In both cases, adverse reactions were generally mild 
GI effects like heartburn, diarrhea and nausea. The biggest controversy 
with these two trials is the use of two different glucosamine salt forms -
HCL and sulfate. The GAIT trial found glucosamine HCL to be ineffective 
alone, but the GUIDE trial did find the sulfate form to be effective alone. 
The question also remains why glucosamine appears more effective in 
combination than as a stand-alone therapy. The place of glucosamine in 
current osteoarthritis patients has yet to be established, but recent stud-
ies have suggested it may have efficacy in some patient populations. 
So, what do you tell a patient who is interested in using glucosamine? 
First, explain that efficacy has only been established in certain patient 
populations, and it may or may not be right for them. Next, you need to 
inform your patient that the only form that has been proven efficacious is 
the oral sulfate form. The sulfate form is typically more expensive (any-
where from $9 to $32 for a one-month supply) because it is more costly 
to manufacture.9 Glucosamine is expensive regardless, but you want to 
make sure your patient gets the most effective product for their money. 
Do not recommend glucosamine cream because efficacy has not been 
established. At least 1,500 mg daily is needed to be beneficial, and 
this dose is often broken up into BID or TIO dosing. Research has also 
proven that glucosamine must be used for a minimum of 30 to 90 days 
to notice any effect.10 Encourage the patient to try at least a 60-day trial 
period before making the decision to continue or discontinue therapy. 
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Chondroitin sulfate 
Chondroitin, found naturally in the human body, is marketed as a 
cartilage matrix enhancer that helps rebuild and prevent the breakdown 
of cartilage, thereby maintaining healthy joint function.11 In the body, it 
is a major component of connective tissue and joint cartilage, and its 
ability to absorb water increases cartilage thickness and its capacity to 
tolerate the impact of compressive forces. Additionally, it inhibits syn-
ovial enzymes, such as elastase and hyaluronidase, which are thought 
to destroy cartilage and, thus, weaken joints. Synthesis of chondroitin 
decreases with age.12 
Chondroitin is one of the most common over-the-counter supplements 
that patients buy in an effort to improve their joint health, yet clinical 
evidence supporting its effectiveness is limited and inconsistent. The 
earliest trials that demonstrated its efficacy were not of high quality.13 
More recent and superior-quality studies show that chondroitin does not 
reduce the pain associated with OA. While chondroitin most likely does 
not have a place in OA therapy for symptom relief, current research 
has examined its place in structural management of OA. Because of its 
structure-modifying effect, chondroitin may slow OA progression. 14 A 
meta-analysis examined this beneficial effect in patients with knee OA 
and determined that it did have a significant protective effect on joint 
narrowing space, but only after two years of daily treatment. Further-
more, this study also showed that chondroitin may slow the radiological 
progression of OA with prolonged daily treatment.15 
A normal dose of chondroitin is 200-400 mg two to three times per day, 
or 800-1,200 mg once daily, most often in combination with glucosamine 
and other supplements. These combination products usually come as 
a 60-day supply (120 count, taken twice daily), and prices range from 
$19.99-$47.99, depending on the number of ingredients and the relative 
milligram strength of each. There are also many dosage forms available, 
including tablets, capsules, softgels, drinks and flavored powder packets 
to add to water.16 
Due to insufficient quality clinical evidence supporting its effectiveness, 
lack of symptom relief and high cost, chondroitin should not be recom-
mended to patients. Further studies need to be performed to determine if 
the structure-modifying effect does slow the progression of OA and if this 
can be associated with any clinically significant outcomes for patients, 
such as improved quality of life. 
MSM 
MSM is an organic compound found in green plants, certain species of 
algae, fruits, vegetables, grains, bovines and humans. It is the oxidized 
metabolite of dimethylsulfoxide (DMSO) and is commercially produced 
by combining DMSO with hydrogen peroxide. Preliminary research 
suggests it might inhibit the degenerative changes in joints, thus helping 
with pain and swelling and possibly improving joint or physical function. 17 
This might be due to the compound's ability to increase blood flow, 
reduce muscle spasms and inhibit type C nerve fibers from transmitting 
pain impulses and its power to limit the release of inflammatory media-
tors. The sulfur present in MSM also is an important element in proteins, 
connective tissues, hormones and enzymes and, therefore, is significant 
in the formation of cartilage.18 MSM has been shown to be safe when 
taken orally in amounts up to 6 g per day for three months, but safety 
when used topically or in pregnancy has not yet been established. 
Adverse effects include nausea, diarrhea, bloating, headache, fatigue, 
insomnia and difficulty concentrating; however, these effects have not 
been very prevalent. Additional side effects in some patients include pru-
ritus and enhanced allergy symptoms. In the treatment of osteoarthritis, 
MSM should be taken as 500 mg three times daily up to 3 g twice daily.17 
A 30-day supply of 1 ,500 mg MSM tablets can cost anywhere from $10 
to $20.19 
A randomized, double-blind, placebo-controlled pilot clinical trial was 
conducted to evaluate the efficacy of MSM in the treatment of osteoar-
thritis pain in the knee. Fifty patients were given either placebo (n=25) or 
3 g of MSM twice daily (n=25) and were evaluated for 12 weeks. Primary 
outcome parameters were evaluated using the Western Ontario and Mc-
Master University Osteoarthritis Index VAS (WOMAC), which included 
pain, stiffness, physical function and aggregated total symptoms. Sec-
ondary parameters included patient and physician global assessments 
(disease status and response to therapy) and overall health-related 
quality of life. Of the 40 patients who completed the study, the MSM 
group was found to have a significant reduction in WOMAC pain and 
impairment of physical function (p<0.05). MSM also was found to sig-
nificantly improve the performance of activities of daily living compared 
to placebo (p<0.05). There was not a significant change in stiffness or 
aggregated total symptoms. Even though there was a statistically sig-
nificant improvement in pain and physical function, the small difference 
in comparison to the placebo group indicates little clinical significance. 
Researchers also state that, although few adverse events were noted, 
the long-term benefits and safety cannot be determined from this trial 
and more studies need to be conducted.20 
On the other hand, another randomized, double-blind, parallel, controlled 
clinical trial that assessed the efficacy of glucosamine, MSM, and their 
combination in osteoarthritis did find significantly positive clinical find-
ings. A total of 118 patients received either 500 mg glucosamine, 500 
mg MSM, glucosamine and MSM, or placebo three times daily for 12 
weeks. Pain, swelling, the Lequesne index (assessed pain or discom-
fort, maximum distance walked and activities of daily living) and use of 
rescue medication were all evaluated as outcome parameters. After 12 
weeks of therapy, MSM alone was found to significantly decrease the 
pain and swelling index from 1.53 ± 0.51 to 0.74 ± 0.65 (p<0.001) with 
the combination product producing even greater effects. The glu-
cosamine/MSM combination also demonstrated a significant reduction in 
the Lequesne index (p<0.001 ). Overall, MSM alone and in combination 
with glucosamine were found to demonstrate significant analgesic and 
anti-inflammatory actions in the treatment of osteoarthritis.21 
Due to the conflicting evidence regarding efficacy and the unknown 
safety of MSM, more studies need to be conducted. Any patients tak-
ing this supplement in the long-term treatment of osteoarthritis should 
consult a physician before beginning use. 
Other Products 
There are numerous other products and therapies thought to have a 
benefit in OA. The table below discusses some of the more popular 
ones, including their possible benefit and presumed effectiveness, based 
on limited clinical evidence: 13 
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Product Possible Benefit Effectiveness 
SA Me Comparable to celecoxib/ Likely effective 
other NSAIDS for decreasing 
OA symptoms with fewer side 
effects. May require longer 
treatment period. 
Avocado/soybean Improves pain, overall disability Possibly effective 
Beta-carotene Slows progression, not Possibly effective 
development of disease 
Camphor (topical} Symptom relief through Effective 
counterirritant effects 
Niacin (Vitamin B3) Improves joint flexibility and Possibly effective 
reduces inflammation 
Vitamin C Reduces risk of cartilage loss Possibly effective 
and disease progression 
Vitamin E No decrease in symptoms, Probably ineffective 
slows cartilage loss, reduces 
risk of disease development 
Insufficient evidence: DMSO, gelatin, ginger, vitamin B5, selenium 
Nonpharmacologic treatment: acupuncture, mineral baths, magnet therapy, yoga 
OTC Regulation 
The lax regulations surrounding dietary supplements are an important 
counseling point for all patients. The Dietary Supplement Health and 
Education Act (OSHEA) of 1994 mandated that the dietary supplement 
manufacturer is responsible for product safety, not the Food and Drug Ad-
ministration (FDA).22 Manufacturers do not need to register their products 
with the FDA before marketing, and the FDA can only withdraw a product 
from the market after multiple serious adverse drug reactions (ADRs) have 
occurred. Some companies choose to undergo investigation and certifica-
tion through paid outside sources, but this is not mandatory.23 The FDA 
can post lists of dietary supplements that may contain harmful ingredients 
but can only pull these products off the market after there have been 
multiple documented cases of serious ADRs (usually death). 24 Encourage 
patients to research the product manufacturer before buying their dietary 
supplements. 
Conclusion 
Osteoarthritis affects 46 million Americans and is the leading cause of dis-
ability .1 As America ages, many are looking for ways to prevent problems or 
treat existing problems without prescription medication. Glucosamine is likely 
to be efficacious, but patients must be careful of which type they buy. MSM 
and chondroitin lack strong evidence for use at present, and MSM has yet to 
prove sat ety, so patients should talk to their doctor prior to starting therapy. 
At this time, there is a definite lack of evidence proving success or failure for 
many natural products on the market; however, as health care professionals, 
it is our responsibility to educate our patients when more evidence has been 
brought to light about the herbal products they may be taking. 
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